Hypotensive Effects of Aqueous Extract of Moringa Stenopetala in Both in Vivo and in Vitro Animal Models

Mengistu, Mekoya (2007) Hypotensive Effects of Aqueous Extract of Moringa Stenopetala in Both in Vivo and in Vitro Animal Models. Masters thesis, Addis Ababa University.

[img] PDF (Hypotensive Effects of Aqueous Extract of Moringa Stenopetala in Both in Vivo and in Vitro Animal Models)
Microsoft Word - final(39).pdf - Accepted Version
Restricted to Repository staff only

Download (1MB) | Request a copy

Abstract

Hypertension is sustained elevation of arterial blood pressure. It is the major cardiovascular risk factor contributing to myocardial infarction, cerbrovascular accidents, congestive heart failure, peripheral vascular insufficiency and premature mortality. Different medicinal plants have been used to treat hypertension. One such plant is Moringa stenopetala, a tree whose leaves, flowers, and fruits are used as vegetable in some areas of Southern Ethiopia. Different parts of M. stenopetala are also used to cure various diseases including hypertension. In this study, the in vivo and in vitro hypotensive properties of aqueous leaf extracts of Moringa stenopetala have been assessed on selected animal model. The crude aqueous leaf extract of M. stenopetala caused significant fall in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial blood pressure (MABP) at the doses of 10, 20, 30 and 40 mg/kg in normotensive anaesthetized guinea pigs (n = 12). The percent fall in SBP was 25.42 ± 4.3% (p = 0.00), 33.3 ± 3.9% (p = 0.00), 41.27 ± 3.7% (p = 0.00), and 51.73 ± 3.9% (p = 0.00) at the respective doses of 10, 20, 30 and 40 mg/kg. At the same dose the percent fall in DBP was 27.76 ± 3.1% (p = 0.00), 38.38 ± 3.7% (p = 0.00), 52.51 ± 4.1% (p = 0.00) and 59.91 ± 3.7% (p = 0.00). The percent fall in MABP was also 26.74 ± 3.6% (p = 0.00), 36.2 ± 3.5% (p = 0.00), 47.62 ± 3.6% (p = 0.00) and 56.39 ± 3.5 % (p = 0.00) at the above respective doses. However, significant percent fall in pulse pressure was observed only at the cumulative dose of 40 mg/kg and the fall was 33.86 ± 8.9% (p = 0.01). The hypotensive effect might have been mediated by non-autonomic nervous system as its effect is not altered by atropine, which is muscarinic receptor blocker of acetylcholine, and propranolol, which is non-selective blocker of β-adrnergic receptors. The in vitro hypothensive study of M. stenopetala was carried out on isolated guinea pig aorta. High-K+ (80mM) induced sustained contraction of the aortic tissue preparation. However, the aqueous leaf extract of M. stenopetala caused dose and time dependent inhibition (vasodilation) of the induced contraction. The significant inhibition of high K+-induced contraction was 36.55 ± 8.64% (p = 0.001), 67.76 ± 9.55% (p = 0.00), and 95.56 ± 3.14% (p = 0.00) at respective doses of 5, 6 and 7 mg/ml (n = 10 and data are expressed as M ± SEM). Thus, the in vivo and in vitro studies justify traditional use of the leaves of M. stenopetala as antihypertensive agent by some localities of Southern Nations Nationalities and Peoples, Ethiopia. Furthermore, acute toxicity study of M. stenopetala showed that the extract was tolerable in mice when tested up to the oral dose of 10 g/kg withno mortality and behavioral changes. This also signifies that the leaves of the plant can be a safe source of food.

Item Type: Thesis (Masters)
Uncontrolled Keywords: Hypertention; Moringa stenopetala; Aqueous extract; in vitro; in vivo; Blood pressure; Acute toxicity; Phytochemical Screening
Subjects: Q Science > QP Physiology
Divisions: Africana
Depositing User: Emmanuel Ndorimana
Date Deposited: 19 Nov 2018 10:15
Last Modified: 19 Nov 2018 10:15
URI: http://thesisbank.jhia.ac.ke/id/eprint/7493

Actions (login required)

View Item View Item